316 related articles for article (PubMed ID: 24469251)
1. Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway.
Tortoriello G; Morris CV; Alpar A; Fuzik J; Shirran SL; Calvigioni D; Keimpema E; Botting CH; Reinecke K; Herdegen T; Courtney M; Hurd YL; Harkany T
EMBO J; 2014 Apr; 33(7):668-85. PubMed ID: 24469251
[TBL] [Abstract][Full Text] [Related]
2. Fetal cannabinoid receptors and the "dis-joint-ed" brain.
Cristino L; Di Marzo V
EMBO J; 2014 Apr; 33(7):665-7. PubMed ID: 24631837
[TBL] [Abstract][Full Text] [Related]
3. Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus.
Laaris N; Good CH; Lupica CR
Neuropharmacology; 2010; 59(1-2):121-7. PubMed ID: 20417220
[TBL] [Abstract][Full Text] [Related]
4. Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure.
Miller S; Daily L; Leishman E; Bradshaw H; Straiker A
Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5904-5911. PubMed ID: 30550613
[TBL] [Abstract][Full Text] [Related]
5. Prenatal exposure to cannabinoids evokes long-lasting functional alterations by targeting CB1 receptors on developing cortical neurons.
de Salas-Quiroga A; Díaz-Alonso J; García-Rincón D; Remmers F; Vega D; Gómez-Cañas M; Lutz B; Guzmán M; Galve-Roperh I
Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13693-8. PubMed ID: 26460022
[TBL] [Abstract][Full Text] [Related]
6. Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects.
Ellgren M; Artmann A; Tkalych O; Gupta A; Hansen HS; Hansen SH; Devi LA; Hurd YL
Eur Neuropsychopharmacol; 2008 Nov; 18(11):826-34. PubMed ID: 18674887
[TBL] [Abstract][Full Text] [Related]
7. SCG10 is a JNK target in the axonal degeneration pathway.
Shin JE; Miller BR; Babetto E; Cho Y; Sasaki Y; Qayum S; Russler EV; Cavalli V; Milbrandt J; DiAntonio A
Proc Natl Acad Sci U S A; 2012 Dec; 109(52):E3696-705. PubMed ID: 23188802
[TBL] [Abstract][Full Text] [Related]
8. Metabolic memory of Δ9-tetrahydrocannabinol exposure in pluripotent stem cells and primordial germ cells-like cells.
Verdikt R; Armstrong AA; Cheng J; Hwang YS; Clark AT; Yang X; Allard P
Elife; 2023 Dec; 12():. PubMed ID: 38150302
[TBL] [Abstract][Full Text] [Related]
9. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.
Feliszek M; Bindila L; Lutz B; Zimmer A; Bilkei-Gorzo A; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):603-12. PubMed ID: 26984820
[TBL] [Abstract][Full Text] [Related]
10. Perinatal exposure to Δ9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens.
Lombard C; Hegde VL; Nagarkatti M; Nagarkatti PS
J Pharmacol Exp Ther; 2011 Nov; 339(2):607-17. PubMed ID: 21831965
[TBL] [Abstract][Full Text] [Related]
11. Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice.
Monory K; Blaudzun H; Massa F; Kaiser N; Lemberger T; Schütz G; Wotjak CT; Lutz B; Marsicano G
PLoS Biol; 2007 Oct; 5(10):e269. PubMed ID: 17927447
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivo Delta9-THC exposure-impaired hippocampal synaptic plasticity.
Fan N; Yang H; Zhang J; Chen C
J Neurochem; 2010 Feb; 112(3):691-702. PubMed ID: 19912468
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.
Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ
J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats.
Di Bartolomeo M; Stark T; Maurel OM; Iannotti FA; Kuchar M; Ruda-Kucerova J; Piscitelli F; Laudani S; Pekarik V; Salomone S; Arosio B; Mechoulam R; Maccarrone M; Drago F; Wotjak CT; Di Marzo V; Vismara M; Dell'Osso B; D'Addario C; Micale V
Pharmacol Res; 2021 Feb; 164():105357. PubMed ID: 33285233
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the apoptotic effect of Delta(9)-tetrahydrocannabinol in the neonatal and adult rat cerebral cortex.
Downer EJ; Gowran A; Campbell VA
Brain Res; 2007 Oct; 1175():39-47. PubMed ID: 17884022
[TBL] [Abstract][Full Text] [Related]
17. Acute Δ9-tetrahydrocannabinol prompts rapid changes in cannabinoid CB
Bonilla-Del Río I; Puente N; Mimenza A; Ramos A; Serrano M; Lekunberri L; Gerrikagoitia I; Christie BR; Nahirney PC; Grandes P
J Comp Neurol; 2021 Jun; 529(9):2332-2346. PubMed ID: 33368252
[TBL] [Abstract][Full Text] [Related]
18. Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212-2 alters migration of early-born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex.
Saez TM; Aronne MP; Caltana L; Brusco AH
J Neurochem; 2014 May; 129(4):637-48. PubMed ID: 24329778
[TBL] [Abstract][Full Text] [Related]
19. Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory.
Sousa VC; Assaife-Lopes N; Ribeiro JA; Pratt JA; Brett RR; Sebastião AM
Neuropsychopharmacology; 2011 Jan; 36(2):472-87. PubMed ID: 20927050
[TBL] [Abstract][Full Text] [Related]
20. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
Falenski KW; Thorpe AJ; Schlosburg JE; Cravatt BF; Abdullah RA; Smith TH; Selley DE; Lichtman AH; Sim-Selley LJ
Neuropsychopharmacology; 2010 Jul; 35(8):1775-87. PubMed ID: 20357755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
